Dietary Regulation of the Gut Microbiota Engineered by a Minimal Defined Bacterial Consortium.

PLoS One 2016 13;11(5):e0155620. Epub 2016 May 13.

Division of Gastroenterology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

We have recently reported that Altered Schaedler Flora (ASF) can be used to durably engineer the gut microbiota to reduce ammonia production as an effective modality to reduce morbidity and mortality in the setting of liver injury. Here we investigated the effects of a low protein diet on ASF colonization and its ability to engineer the microbiota. Initially, ASF inoculation was similar between mice fed a normal protein diet or low protein diet, but the outgrowth of gut microbiota differed over the ensuing month. Notable was the inability of the dominant Parabacteroides ASF taxon to exclude other taxa belonging to the Bacteroidetes phylum in the setting of a low protein diet. Instead, a poorly classified yet highly represented Bacteroidetes family, S24-7, returned within 4 weeks of inoculation in mice fed a low protein diet, demonstrating a reduction in ASF resilience in response to dietary stress. Nevertheless, fecal ammonia levels remained significantly lower than those observed in mice on the same low protein diet that received a transplant of normal feces. No deleterious effects were observed in host physiology due to ASF inoculation into mice on a low protein diet. In total, these results demonstrate that low protein diet can have a pronounced effect on engineering the gut microbiota but modulation of ammonia is preserved.

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0155620PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866709PMC
July 2017
20 Reads

Publication Analysis

Top Keywords

protein diet
32
low protein
28
gut microbiota
16
inoculation mice
12
mice fed
8
diet
8
protein
8
asf inoculation
8
mice low
8
low
7
asf
6
microbiota
5
month notable
4
ensuing month
4
normal feces
4
notable inability
4
inability dominant
4
differed ensuing
4
dominant parabacteroides
4
received transplant
4

References

(Supplied by CrossRef)
What Is the Value of a Food and Drug Administration Investigational New Drug for Fecal Microbiota Transplantation in Clostridium difficile Infection?
GA Hecht et al.
Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association 2013

Similar Publications